Janssen-Cilag Ltd.
🇬🇧United Kingdom
A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-11-17
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Janssen-Cilag Ltd.
- Target Recruit Count
- 19
- Registration Number
- NCT00254930
© Copyright 2024. All Rights Reserved by MedPath